1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > World Generic Markets 02 MARCH 2015

World Generic Markets 02 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Roche Most At Risk From Upcoming Biosimilar Oncology Market
Industry Brief - Merck Provides MPP With Paediatric Raltegravir Licence
Industry Brief - Sucampo/R-Tech Settlement Overcomes Par Unoprostone ANDA
Industry Brief - Sandoz Launches Telmisartan In US
Industry Brief - Cambrex Expands Iowa API Facility
Industry Trend Analysis - Patent Ruling Edges Pulmicort Respules Toward Lifecycle End
Industry Brief - Teva Launches Enoxaparin And Linezolid Products In US
Industry Brief - Apotex' Second Biosimilar Application Accepted By FDA
Industry Brief - Actavis Gains US Buprenorphine Approval
Industry Brief - TWi To Sell Megestrol And Lidocaine Products In US
Industry Brief - Glenmark Launches Trandolapril+Verapamil In US
Industry Brief - Hospira Launches Inflectra In Remaining European Countries
Industry Brief - Use Of Biosimilar Infliximab Could Produce Significant CD Savings
Industry Brief - Acino Gains German Rivastigmine Court Victory
Industry Brief - Actavis To Divest Pharmatech To TPG
Industry Trend Analysis - Actavis' Future Dominated By Brands, But Generics Remain Important
Industry Brief - Actavis To Adopt Allergan Name
Industry Brief - Lupin And Celon Enter Fluticasone+Salmeterol Agreement
Industry Trend Analysis - Complex Sofosbuvir Relationship Favours Mylan
Industry Brief - Teva Commences USD1bn Debt Tender Offer

Table Of Contents

World Generic Markets 02 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...


Download Unlimited Documents from Trusted Public Sources

Biosimilar Industry in Europe

  • November 2016
    42 pages
  • Biosimilar  

  • Europe  

View report >

Pathology Statistics in Canada

  • October 2016
    2 pages
  • Biosimilar  

  • Canada  

    North America  

View report >

Global Breast Cancer Statistics

  • October 2016
    2 pages
  • Breast Cancer  

    Biosimilar  

  • Europe  

    World  

    Hungary  

View report >

Bioprocessing Industry

3 months ago

Biosimilar Statistics

3 months ago

Biosimilar Statistics

3 months ago

Related Market Segments :

Biosimilar

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.